Dompé evaluating intranasal spray for NAION in phase 3 study
The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment…
All ophthalmologists should help address global visual impairment
The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million…
Healio AI, ASCRS partner to expand ophthalmology learning
Healio AI and the American Society of Cataract and Refractive Surgery, or ASCRS, announced a partnership to optimize available educational…
Changes, challenges abound in eye care in developing nations
Click here to read the Point/Counter to this Cover Story.Through the combined efforts of local governments, pioneering institutions, global health…
Phase 3 trial to study urcosimod in neuropathic corneal pain
The FDA favorably reviewed plans for a phase 3 trial of urcosimod, which is being investigated for the treatment of…
Lupin recalls more than 2.5 million eye drops
More than 2.5 million bottles of steroid eye drops aimed at relieving inflammation have been recalled, according to the FDA.Lupin…
Healio wins six APEX awards for publication excellence
Healio has garnered six APEX awards, including one Grand Award, this year.The APEX awards highlight outstanding achievement in graphic design,…
Physician payment reforms ‘a step in the right direction,’ but further change needed
AMA recently reiterated its call for Congress to pass several reforms that would increase physician payment and improve health care…
Single sura-vec injection improved early diabetic retinopathy
PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according…
What do you wish you knew before starting the innovation process?
Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.”A few years back, one…
Human stem cell-derived RPE shows safety, improved vision in GA
DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements…
Sutureless posterior chamber IOL has good long-term outcomes
Patients who underwent sutureless scleral fixation of a one-piece IOL had good outcomes at 5 years, according to a study…
FDA clears Be Free Day toric contact lenses
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA cleared Be Free Day toric…
Embrace next-generation IOL optics to expand patient vision
The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle dependence or an expanded…
Is MAHA ready for the health challenges of rural America?
This month’s Healio Exclusive focuses on one of the most complex — and frankly saddest — realities in American health…